Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas

Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas

Abstract Glioma, which accounts for more than 30% of primary central nervous system tumours, is characterised by symptoms such as headaches, epilepsy, and blurred vision. Glioblastoma multiforme is the most aggressive, malignant, and lethal brain tumour in adults. Even with progressive combination t...

Full description

Bibliographic Details
Main Authors: Qing Zhang, Wei Xiang, Dong-ye Yi, Bing-zhou Xue, Wan-wan Wen, Ahmed Abdelmaksoud, Nan-xiang Xiong, Xiao-bing Jiang, Hong-yang Zhao, Peng Fu
Format: Article
Language:English
Published: BMC 2018-08-01
Series:Stem Cell Research & Therapy
Subjects:
Mesenchymal stem cells (MSCs)
Gliomas
MSC-based therapy
Current status
Potential challenges
Online Access:http://link.springer.com/article/10.1186/s13287-018-0977-z

Internet

http://link.springer.com/article/10.1186/s13287-018-0977-z

Similar Items